Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B1 | P15538 | 2/20 | 0.43 |
| ▸ | CYP11B2 | P19099 | 2/20 | 0.43 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.43 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.42 |
| ▸ | TDP2 | O95551 | 1/20 | 0.41 |
| ▸ | HSD17B3 | P37058 | 2/20 | 0.41 |
| ▸ | BMPR1B | O00238 | 3/20 | 0.40 |
| ▸ | BMPR1A | P36894 | 3/20 | 0.40 |
| ▸ | ACVRL1 | P37023 | 3/20 | 0.40 |
| ▸ | ACVR1 | Q04771 | 3/20 | 0.40 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.38 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13326613 | 0.92 | PDE5A (0.43) | CYP11B1CYP11B2CYP17A1CYP1A2CYP19A1 | |
| SCHEMBL5068071 | 0.81 | ALDH1A1 (0.43) | CYP1A2ACVR1SMN1; SMN2NPC1MAPT | |
| SCHEMBL5069422 | 0.79 | MAOA (0.41) | HSD17B3ACVR1MAPT | |
| SCHEMBL13827544 | 0.79 | FAAH (0.44) | CYP11B1CYP11B2SRD5A1TDP2HSD17B3 | |
| SCHEMBL13326569 | 0.78 | ACVRL1 (0.36) | CYP11B1CYP11B2CYP17A1CYP1A2CYP19A1 | |
| SCHEMBL769234 | 0.77 | ACVRL1 (0.71) | CYP11B1CYP11B2CYP17A1CYP1A2CYP19A1 | |
| SCHEMBL20905279 | 0.77 | CYP11B1 (0.50) | CYP11B1CYP11B2CYP17A1CYP1A2CYP19A1 | |
| SCHEMBL2493673 | 0.77 | MAOA (0.55) | DRD2MAPTMAPK1 | |
| SCHEMBL16502139 | 0.76 | APP (0.41) | CYP11B1CYP11B2SRD5A1TDP2HSD17B3 | |
| SCHEMBL18596812 | 0.76 | HSD17B3 (0.36) | CYP11B1CYP11B2CYP17A1CYP1A2CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7718278-B2 | Anthrancene derivative compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2010-05-18 | — | — | US | disclosed |
| US-20080122346-A1 | ANTHRANCENE DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2008-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080122346-A1 | ANTHRANCENE DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | AR, CRY2, ANTXR2 | CYP11B1 424/4885CYP11B2 404/4885CYP17A1 1104/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.